Brightside Health Raises Strategic Series C, Welcomes Trip Hofer to Board of Directors

With Over $100M in Total Funding, the Telemental Health Company is Poised for its Next Phase of Growth Telemental health company Brightside Health today announced a strategic Series C raise led by S32, as well as the appointment of industry titan Trip Hofer to the Board of Directors to advise on go-to-market strategy and execution. This news builds on the company’s recent momentum, including new and expanded payer partnerships to support Medicaid and Medicare lives and notable results for its award-winning Crisis Care program for individuals with elevated suicide risk. Brightside Health serves people with mild to severe clinical depression, anxiety, and other mood disorders, including those with elevated suicide risk, through precision psychiatry, clinically proven therapy, and Crisis Care. The impressive activity and results attracted lead investor S32, along with Kennedy Lewis, Time BioVentures, and Anne Wojcicki (Redwood Pacific). Existing investors ACME, Mousse Partners, and Triventures also contributed to the raise of $33M, an intentional amount that will be used to fuel Brightside Health’s growth into new markets and new offerings. All of this comes at a critical time for the country as one in five adults live with mental illness, such as anxiety or depression. “Brightside Health is on an exciting trajectory, and S32 is thrilled to support their mission to make mental healthcare more easily accessible to everyone,” said Mike Pellini, MD, General Partner at S3...
Source: EMR and HIPAA - Category: Information Technology Authors: Tags: Health IT Company Healthcare IT ACME Anne Wojcicki Brad Kittredge Brightside Health Health IT Funding Health IT Fundings Health IT Investment Kennedy Lewis Mike Pellini Mousse Partners Redwood Pacific S32 Time BioVentures Tri Source Type: blogs